This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Dublin City University. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: The Innovations of Kenneth McMahon
Introduction
Kenneth McMahon is an accomplished inventor based in County Meath, Ireland. He has made significant contributions to the field of glycan and glycoconjugate analysis through his innovative work. His research focuses on peptide analogues that enhance the understanding and purification of biomolecules.
Latest Patents
Kenneth McMahon holds a patent for "Peptide analogues of PA-IL and their utility for glycan and glycoconjugate analysis and purification." This patent includes peptide analogs of PA-IL and compositions containing them. The PA-IL peptide analogs have altered carbohydrate binding specificity compared to the original PA-IL of SEQ ID NO:1. The analogs feature amino acid substitutions at specific positions, including 50, 52, and 53 of SEQ ID NO:1. Additionally, the patent outlines methods for detecting changes in glycosylation of carbohydrates and for separating biomolecules that contain glycoproteins or glycoconjugates.
Career Highlights
Kenneth McMahon is affiliated with Dublin City University, where he continues to advance his research and contribute to the academic community. His work has garnered attention for its potential applications in biochemistry and molecular biology.
Collaborations
Kenneth collaborates with notable colleagues, including Roisin Thompson and Michael O'Connell. Their combined expertise enhances the research output and innovation within their field.
Conclusion
Kenneth McMahon's contributions to the field of glycan and glycoconjugate analysis through his patented innovations demonstrate his commitment to advancing scientific knowledge. His work at Dublin City University and collaborations with esteemed colleagues further solidify his impact in the realm of biochemistry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
